A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models.
Eric S LightcapPengfei YuStephen GrossmanKeli SongMithun KhattarKristina XegaXingyue HeJames M GavinHisashi ImaichiJames J GarnseyErik KoenigHongru ZhangZhen LuPooja ShahYu FuMichael A MilhollenBeryl A HattonJessica RicebergVaishali ShindeCong LiJames MinissaleXiaofeng YangDylan EnglandRichard A KlinghofferSteven P LangstonKatherine GalvinGary ShapiroSai M PulukuriSerge Y FuchsDennis HuszarPublished in: Science translational medicine (2021)
[Figure: see text].